Yingjixing Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yingjixing Luo has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Zhiying Yang
Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, China
3 shared publications - Tianxiao Wang
Peking University China‐Japan Friendship School of Clinical Medicine Beijing China
2 shared publications - Duo Li
Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
1 shared publication Hanchun Huang
Department of Hepatobiliary and Pancreatic Surgery China‐Japan Friendship Hospital Beijing China
1 shared publicationJia Huang
Department of Hepatobiliary and Pancreatic Surgery China‐Japan Friendship Hospital Beijing China
1 shared publicationLi Xu
Department of Hepatobiliary and Pancreatic Surgery China‐Japan Friendship Hospital Beijing China
1 shared publication
Latest Publications
- Open Access
- 13 October 2025
- Published by Wiley in Aging Medicine
- Vol. 8 (5) , 447-457
Analysis of Outcomes in Pancreaticoduodenectomy for Elderly Patients Aged 80 and Above: A Retrospective Study Using Inverse Probability of Treatment Weighting
Objectives: With an aging population, more elderly individuals are facing the decision to undergo complex surgeries, such as pancreaticoduodenectomy (PD). This study evaluates the safety and feasibility of PD in patients aged 80 and above. Methods: We conducted a retrospective analysis of 422 patients who underwent PD between August 2011 and January 2024. The patients were categorized into three age groups: < 60 years, 60–79 years, and ≥ 80 years. We adjusted for baseline characteristics using inverse probability of treatment weighting (IPTW) and compared postoperative complications, hospital stay durations, 90‐day mortality, and long‐term survival across the groups. A subgroup analysis identified factors associated with complications and 90‐day mortality. Results: After IPTW adjustment, no significant differences in complications or long‐term survival were observed between the groups. However, the ≥ 80‐year group had a significantly higher 90‐day mortality rate (13.64%) compared to the 60–79 years group (2.00%) and the < 60 years group (1.46%) ( p = 0.002). Subgroup analysis identified hypertension, coronary artery disease (CAD), and nutritional risk (NRS ≥ 3) as independent risk factors for complications, while age ≥ 80 and CAD were associated with higher 90‐day mortality. Conclusions: Age does not significantly impact postoperative complications or long‐term survival following PD. While PD is safe and feasible for the elderly, those with cardiovascular comorbidities or poor nutritional status face higher risks of complications and mortality. A comprehensive preoperative assessment is critical to minimizing these risks.
- 13 October 2025
- Published by Wiley in Aging Medicine
- Vol. 8 (5) , 447-457
Open AccessAnalysis of Outcomes in Pancreaticoduodenectomy for Elderly Patients Aged 80 and Above: A Retrospective Study Using Inverse Probability of Treatment Weighting
Objectives: With an aging population, more elderly individuals are facing the decision to undergo complex surgeries, such as pancreaticoduodenectomy (PD). This study evaluates the safety and feasibility of PD in patients aged 80 and above. Methods: We conducted a retrospective analysis of 422 patients who underwent PD between August 2011 and January 2024. The patients were categorized into three age groups: < 60 years, 60–79 years, and ≥ 80 years. We adjusted for baseline characteristics using inverse probability of treatment weighting (IPTW) and compared postoperative complications, hospital stay durations, 90‐day mortality, and long‐term survival across the groups. A subgroup analysis identified factors associated with complications and 90‐day mortality. Results: After IPTW adjustment, no significant differences in complications or long‐term survival were observed between the groups. However, the ≥ 80‐year group had a significantly higher 90‐day mortality rate (13.64%) compared to the 60–79 years group (2.00%) and the < 60 years group (1.46%) ( p = 0.002). Subgroup analysis identified hypertension, coronary artery disease (CAD), and nutritional risk (NRS ≥ 3) as independent risk factors for complications, while age ≥ 80 and CAD were associated with higher 90‐day mortality. Conclusions: Age does not significantly impact postoperative complications or long‐term survival following PD. While PD is safe and feasible for the elderly, those with cardiovascular comorbidities or poor nutritional status face higher risks of complications and mortality. A comprehensive preoperative assessment is critical to minimizing these risks.
- Open Access
- 22 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (2) , 1041-1048
The application of hepatopancreatoduodenectomy in advanced gallbladder carcinoma: Patient selection, surgical outcomes and influence on survival compared to radical cholecystectomy
- 22 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (2) , 1041-1048
Open AccessThe application of hepatopancreatoduodenectomy in advanced gallbladder carcinoma: Patient selection, surgical outcomes and influence on survival compared to radical cholecystectomy
- Open Access
- 1 June 2024
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 13 (3) , 444-459
Laparoscopic versus open surgery in treating patients with gallbladder cancer: a systematic review and meta-analysis
Background: Concerns over the security of laparoscopic radical operation for gallbladder cancer (GBC) persist. This systematic review and meta-analysis attempted to compare the safety and efficacy of laparoscopic surgery (LS) versus open surgery (OS) in the treatment of GBC. Methods: The PubMed, EMBASE, and Web of Science were searched from inception to July 18, 2022. Literature search, quality assessment, and data extraction were completed independently and in duplicate. Effect-size estimates expressed as weighted mean difference (WMD) or odds ratio (OR) with 95% confidence interval (CI) were derived under the random-effects model. Results: A total of 27 independent studies including 2,868 participants were meta-analyzed. Significance was noted for intraoperative blood loss (WMD: −117.194, 95% CI: −170.188 to 64.201, PConclusions: Our findings indicated that LS statistically had better 2-year survival rates, less intraoperative bleeding, shorter hospitalization times, and lower rates of complications than OS. However, the superiority and even the safety of LS still remain an open question due to the impact of incidental GBC, unaccounted heterogeneity, publication bias, lymph node dissection, and port-site metastasis.
- 1 June 2024
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 13 (3) , 444-459
Open AccessLaparoscopic versus open surgery in treating patients with gallbladder cancer: a systematic review and meta-analysis
Background: Concerns over the security of laparoscopic radical operation for gallbladder cancer (GBC) persist. This systematic review and meta-analysis attempted to compare the safety and efficacy of laparoscopic surgery (LS) versus open surgery (OS) in the treatment of GBC. Methods: The PubMed, EMBASE, and Web of Science were searched from inception to July 18, 2022. Literature search, quality assessment, and data extraction were completed independently and in duplicate. Effect-size estimates expressed as weighted mean difference (WMD) or odds ratio (OR) with 95% confidence interval (CI) were derived under the random-effects model. Results: A total of 27 independent studies including 2,868 participants were meta-analyzed. Significance was noted for intraoperative blood loss (WMD: −117.194, 95% CI: −170.188 to 64.201, PConclusions: Our findings indicated that LS statistically had better 2-year survival rates, less intraoperative bleeding, shorter hospitalization times, and lower rates of complications than OS. However, the superiority and even the safety of LS still remain an open question due to the impact of incidental GBC, unaccounted heterogeneity, publication bias, lymph node dissection, and port-site metastasis.